Literature DB >> 3246354

High-level synthesis in Escherichia coli of functional cap-binding eukaryotic initiation factor eIF-4E and affinity purification using a simplified cap-analog resin.

I Edery1, M Altmann, N Sonenberg.   

Abstract

Numerous studies have established the important role that eukaryotic initiation factor-4E (eIF-4E) plays during protein biosynthesis. However, biochemical characterization of eIF-4E has proved difficult, mainly because of its low abundance in cells. To facilitate studies on eIF-4E, we have overexpressed Saccharomyces cerevisiae eIF-4E in Escherichia coli. The isolation of eIF-4E was simplified by using a cap-analog affinity matrix (agarose resin) that is considerably less demanding to prepare than those previously reported. We describe a simple and rapid purification scheme that can yield 2-5 micrograms of a homogenous and active preparation of eIF-4E from 1 ml of E. coli culture. E. coli-expressed eIF-4E is active as determined by its ability to bind the cap structure. The results demonstrate that the cap-binding activity of eIF-4E is not dependent on the presence of other proteins that are present at low levels in eIF-4E preparations isolated from eukaryotic cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3246354     DOI: 10.1016/0378-1119(88)90184-9

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  47 in total

1.  mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E.

Authors:  D C Schwartz; R Parker
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

2.  Phosphorylation of eIF4E attenuates its interaction with mRNA 5' cap analogs by electrostatic repulsion: intein-mediated protein ligation strategy to obtain phosphorylated protein.

Authors:  Joanna Zuberek; Aleksandra Wyslouch-Cieszynska; Anna Niedzwiecka; Michal Dadlez; Janusz Stepinski; Wojciech Augustyniak; Anne-Claude Gingras; Zhibo Zhang; Stephen K Burley; Nahum Sonenberg; Ryszard Stolarski; Edward Darzynkiewicz
Journal:  RNA       Date:  2003-01       Impact factor: 4.942

3.  Bicoid associates with the 5'-cap-bound complex of caudal mRNA and represses translation.

Authors:  Dierk Niessing; Stephen Blanke; Herbert Jäckle
Journal:  Genes Dev       Date:  2002-10-01       Impact factor: 11.361

4.  Novel cap analogs for in vitro synthesis of mRNAs with high translational efficiency.

Authors:  Ewa Grudzien; Janusz Stepinski; Marzena Jankowska-Anyszka; Ryszard Stolarski; Edward Darzynkiewicz; Robert E Rhoads
Journal:  RNA       Date:  2004-09       Impact factor: 4.942

5.  Affinity-based separations and purifications. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1991-01       Impact factor: 2.926

6.  Kinetic mechanism for assembly of the m7GpppG.eIF4E.eIF4G complex.

Authors:  Sergey V Slepenkov; Nadejda L Korneeva; Robert E Rhoads
Journal:  J Biol Chem       Date:  2008-07-09       Impact factor: 5.157

7.  Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1.

Authors:  Naotaka Sekiyama; Haribabu Arthanari; Evangelos Papadopoulos; Ricard A Rodriguez-Mias; Gerhard Wagner; Mélissa Léger-Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

8.  A cell-penetrant lactam-stapled peptide for targeting eIF4E protein-protein interactions.

Authors:  Erin E Gallagher; Arya Menon; Alyah F Chmiel; Kirsten Deprey; Joshua A Kritzer; Amanda L Garner
Journal:  Eur J Med Chem       Date:  2020-07-25       Impact factor: 6.514

9.  Internal and overall motions of the translation factor eIF4E: cap binding and insertion in a CHAPS detergent micelle.

Authors:  A M McGuire; H Matsuo; G Wagner
Journal:  J Biomol NMR       Date:  1998-07       Impact factor: 2.835

10.  PRAK, a novel protein kinase regulated by the p38 MAP kinase.

Authors:  L New; Y Jiang; M Zhao; K Liu; W Zhu; L J Flood; Y Kato; G C Parry; J Han
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.